Difference between revisions of "Ibandronate (Boniva)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m (Text replace - "Class: " to "Class/mechanism: ")
Line 2: Line 2:
  
 
==General information==
 
==General information==
Class: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.<ref name="insert">[http://www.gene.com/download/pdf/boniva_tablets_prescribing.pdf Ibandronate (Boniva) package insert]</ref><ref>[[Media:Ibandronate.pdf | Ibandronate (Boniva) package insert (locally hosted backup)]]</ref><ref name="injection">[http://www.gene.com/download/pdf/boniva_injection_prescribing.pdf Ibandronate injection (Boniva injection) package insert]</ref><ref>[[Media:Ibandronateinjection.pdf | Ibandronate injection (Boniva injection) package insert (locally hosted backup)]]</ref><ref>[http://www.gene.com/patients/medicines/boniva-tablets Boniva manufacturer's website]</ref>
+
Class/mechanism: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.<ref name="insert">[http://www.gene.com/download/pdf/boniva_tablets_prescribing.pdf Ibandronate (Boniva) package insert]</ref><ref>[[Media:Ibandronate.pdf | Ibandronate (Boniva) package insert (locally hosted backup)]]</ref><ref name="injection">[http://www.gene.com/download/pdf/boniva_injection_prescribing.pdf Ibandronate injection (Boniva injection) package insert]</ref><ref>[[Media:Ibandronateinjection.pdf | Ibandronate injection (Boniva injection) package insert (locally hosted backup)]]</ref><ref>[http://www.gene.com/patients/medicines/boniva-tablets Boniva manufacturer's website]</ref>
 
<br>Route: PO, IV
 
<br>Route: PO, IV
 
<br>Extravasation: no information
 
<br>Extravasation: no information

Revision as of 17:03, 2 May 2013

Also known as Ai Ben, Bandrobon, Bandrone, Bondenza, Bondronat, Bonviva, Femorel, ibandronate sodium, ibandronic acid, Jia Nuo Shun.

General information

Class/mechanism: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.[1][2][3][4][5]
Route: PO, IV
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

References